XML 24 R4.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
In Thousands, except Share data, unless otherwise specified
 3 Months Ended 6 Months Ended 12 Months Ended
Dec. 31, 2011
Dec. 31, 2010
Dec. 31, 2011
Dec. 31, 2010
Jun. 30, 2011
CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract]          
Revenues $ 231    $ 385      
Research and development expenses (2,976) (2,186) (5,844) (3,687) (8,311)
Less participation by the Office of the Chief Scientist and other parties 1,902 608 1,921 1,111 1,682
Research and development expenses, net (1,074) (1,578) (3,923) (2,576) (6,629)
General and administrative expenses (1,275) (1,246) (2,912) (2,002) (4,485)
Operating loss (2,118) (2,824) (6,450) (4,578) (11,114)
Financial (expenses) income, net 126 3 (35) 68 266
Net loss for the period $ (1,992) $ (2,821) $ (6,485) $ (4,510) $ (10,848)
Loss per share:          
Basic and diluted net loss per share $ (0.05) $ (0.11) $ (0.15) $ (0.2) $ (0.35)
Weighted average number of shares used in computing basic and diluted net loss per share 43,669,466 24,897,022 43,225,017 22,954,736 31,198,825